Puma Biotechnology's total assets for Q3 2024 were $220.72M, an increase of 7.67% from the previous quarter. PBYI total liabilities were $149.63M for the fiscal quarter, a -4.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.